We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$77.4B
AUM Growth
-$741M
(-0.95%)
Cap. Flow
-$676M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,421
New
35
Increased
882
Reduced
429
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$347M |
| 2 |
RTX Corp
RTX
|
+$322M |
| 3 |
Synopsys
SNPS
|
+$228M |
| 4 |
Cadence Design Systems
CDNS
|
+$227M |
| 5 |
Manhattan Associates
MANH
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$383M |
| 2 |
Broadcom
AVGO
|
+$320M |
| 3 |
Gilead Sciences
GILD
|
+$281M |
| 4 |
Newmont
NEM
|
+$261M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.99% |
| 2 | Materials | 26.22% |
| 3 | Healthcare | 8.42% |
| 4 | Industrials | 7.31% |
| 5 | Financials | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Cellebrite
CLBT
$3.9B
| $689K | ﹤0.01% |
35,436
+6,448
| +22% | +$136K |
|
1102
Roku
ROKU
$21.8B
| $678K | ﹤0.01% |
9,628
+549
| +6% | +$43.9K |
|
|
GRAL
1103
GRAIL Inc
GRAL
$3.18B
| $676K | ﹤0.01% |
26,467
-141
| -0.5% | -$4.36K |
|
1104
DaVita
DVA
$12.1B
| $671K | ﹤0.01% |
4,386
+154
| +4% | +$24.2K |
|
1105
Encompass Health
EHC
$11B
| $664K | ﹤0.01% |
6,556
-866
| -12% | -$84.6K |
|
1106
Camtek
CAMT
$6.89B
| $658K | ﹤0.01% |
11,231
+665
| +6% | +$53.5K |
|
1107
BlackRock 2037 Municipal Target Term Trust
BMN
$155M
| $653K | ﹤0.01% |
25,764
-4,998
| -16% | -$127K |
|
1108
The Ensign Group
ENSG
$10.4B
| $649K | ﹤0.01% |
+5,018
| New | +$664K |
|
1109
Halozyme
HALO
$9.91B
| $645K | ﹤0.01% |
10,105
-1,005
| -9% | -$58.4K |
|
|
HOLX
1110
DELISTED
Hologic
HOLX
| $640K | ﹤0.01% |
10,365
+1,836
| +22% | +$122K |
|
1111
National Health Investors
NHI
$3.64B
| $640K | ﹤0.01% |
8,669
+710
| +9% | +$50.1K |
|
|
TIGR
1112
UP Fintech Holding
TIGR
$860M
| $637K | ﹤0.01% |
74,181
| – | – |
|
|
BTA
1113
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $635K | ﹤0.01% |
65,522
-3,362
| -5% | -$33.1K |
|
1114
ENI
E
$76.5B
| $635K | ﹤0.01% |
20,515
+1,072
| +6% | +$31.3K |
|
1115
Broadstone Net Lease
BNL
$4.07B
| $634K | ﹤0.01% |
37,220
+1,490
| +4% | +$24.2K |
|
1116
American International
AIG
$42.5B
| $625K | ﹤0.01% |
7,188
+535
| +8% | +$41.6K |
|
1117
Douglas Emmett
DEI
$1.98B
| $617K | ﹤0.01% |
38,531
+2,625
| +7% | +$44.5K |
|
1118
Boyd Gaming
BYD
$6.13B
| $610K | ﹤0.01% |
9,264
-1,155
| -11% | -$84.7K |
|
1119
McCormick & Company Non-Voting
MKC
$14.1B
| $603K | ﹤0.01% |
7,327
+410
| +6% | +$32.1K |
|
1120
ZIM Integrated Shipping Services
ZIM
$3.2B
| $598K | ﹤0.01% |
40,963
+2,426
| +6% | +$45.6K |
|
1121
Kosmos Energy
KOS
$1.4B
| $594K | ﹤0.01% |
260,321
+158,104
| +155% | +$466K |
|
|
ELP
1122
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $589K | ﹤0.01% |
80,601
-5,328
| -6% | -$35.9K |
|
1123
Silicon Motion
SIMO
$8.36B
| $589K | ﹤0.01% |
11,652
+3,381
| +41% | +$183K |
|
1124
Hawaiian Electric Industries
HE
$2.17B
| $588K | ﹤0.01% |
53,677
+4,446
| +9% | +$44.9K |
|
|
GRP.U
1125
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $586K | ﹤0.01% |
12,565
+503
| +4% | +$24K |
|
Similar funds
VanEck Associates's Q1 2025 Portfolio in Review
As of Q1 2025, VanEck Associates held 1,421 positions worth $77.4B, down 0.95% from $78.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.5%. VanEck Associates opened 35 new positions and exited 29, leaving the 1,421-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 41% a quarter earlier, followed by Materials and Healthcare.
- VanEck Associates's largest Q1 2025 buy was Philip Morris: 2,449,251 shares worth $389M.
- VanEck Associates added most to RTX Corp in Q1 2025, an estimated $322M increase.
- VanEck Associates's biggest Q1 2025 reduction was TSMC, cutting an estimated $383M.
- VanEck Associates fully exited Celestica in Q1 2025, selling an estimated $9.19M.
- VanEck Associates's ten largest holdings make up 26% of its $77.4B portfolio in Q1 2025.
- VanEck Associates opened 35 new positions and closed 29 in Q1 2025.
- VanEck Associates's portfolio value fell 0.95% quarter-over-quarter to $77.4B.
Based on VanEck Associates's 13F filing for Q1 2025, filed 15 May 2025.